Trade Mark Journal No.2026/030 24 July 2026

UK00004416295 15 July 2026 (5)

YULITVY

International priority date claimed: 13 July 2026 (United States of America) (99936514)

Class 5: Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of immune system diseases and disorders; antibodies for the treatment of immune system diseases and disorders; antibodies for the treatment of autoimmune diseases and disorders.

Biogen MA Inc.

Representative: Finnegan Europe LLP